Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein

Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein

The acute phase protein Serum Amyloid A (SAA) is synthesised by the liver in response to inflammatory stimuli. Previous studies have revealed that SAA may be a better biomarker of disease activity in inflammatory bowel disease (IBD) compared to C-reactive protein (CRP). This retrospective monocentri...

Full description

Bibliographic Details
Main Authors: Marie Stute, Martin Kreysing, Markus Zorn, Patrick Michl, Annika Gauss
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
Serum Amyloid A
SAA
inflammatory bowel disease
biomarker
Crohn’s disease
ulcerative colitis
Online Access:https://www.mdpi.com/1422-0067/25/2/1177

Internet

https://www.mdpi.com/1422-0067/25/2/1177

Similar Items